IL17RD anticorps (PE)
Aperçu rapide pour IL17RD anticorps (PE) (ABIN2176977)
Antigène
Voir toutes IL17RD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain
-
Homologie
- Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human IL-17RD
-
Isotype
- IgG
-
-
-
-
Indications d'application
- FCM(1:20-100)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- IL17RD (Interleukin 17 Receptor D (IL17RD))
-
Autre désignation
- Il-17rd
-
Sujet
-
Synonyms: Interleukin-17 receptor D, IL17RD, DKFZp434N1928, FLJ35755, hSef, IL 17 receptor D, IL 17RD, IL17 receptor D, IL17Rhom, IL17RLM, Interleukin 17 receptor D, Interleukin 17 receptor like protein, Interleukin17 receptor D, MGC133309, SEF, Sef homolog, I17RD_HUMAN.
Background: Feedback inhibitor of fibroblast growth factor mediated Ras-MAPK signaling and ERK activation. May inhibit FGF-induced FGFR1 tyrosine phosphorylation. Regulates the nuclear ERK signaling pathway by spatially blocking nuclear translocation of activated ERK without inhibiting cytoplasmic phosphorylation of ERK. Mediates JNK activation and may be involved in apoptosis.
-
ID gène
- 54756
-
Pathways
- Toll-Like Receptors Cascades
Antigène
-